Applied Biosystems and Illumina file suits. (Executive Briefing).San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , CA 12/5/02 -- Illumina has announced that Applied Biosystems (ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. ) filed suit against the company alleging infringement of patents related to ABI's oligo ligation ligation /li·ga·tion/ (li-ga´shun) the application of a ligature. tubal ligation sterilization of the female by constricting, severing, or crushing the uterine tubes. assay and that Illumina breached the companies' 1999 joint development agreement. Following the filing, Illumina filed suit against ABI, stating that ABI had breached the joint development agreement. Illumina President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. said that ABI's filing was "an effort to restrain us from selling our independently developed system." Illumina said the launch of the companies' jointly developed genotyping system was delayed by ABI twice and that it has no information on when ABI plans to complete the project. ABI issued no statement regarding the suit. These events suggest that ABI has no plans for commercializing the product. According to Illumina, the system was initially slated for launch in mid 2002 with ABI providing the instruments, SNP SNP Scottish National Party Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily assay reagents, software and worldwide market, and Illumina providing the arrays. ABI contributed $10 million in development support funding. In July, Illumina announced it would launch its own high-throughput SNP genotyping system for shipment in the fourth quarter. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion